Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
33.36
+0.20 (0.62%)
At close: May 12, 2025, 4:00 PM
33.34
-0.01 (-0.04%)
After-hours: May 12, 2025, 6:13 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $18.75 billion as of May 12, 2025. Its market cap has increased by 50.05% in one year.
Market Cap
18.75B
Enterprise Value
25.27B
1-Year Change
50.05%
Ranking
Category
Stock Price
$33.36
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $18.75B, an increase of 18.99%. That is a compound annual growth rate of 3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 13.97B | 23.24% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |